The hypothesis to be examined in this proposal is that chronic venous insufficiency is the result of damage to the vein caused by an inflammatory response induced in the vein wall by thrombosis. The overall goal is a better understanding of the cellular and molecular mechanisms of inflammation that occur in the vein wall as a consequence of venous thrombosis. Using a model of IVC thrombosis in the rat, the study will: (1) characterize the temporal sequence and subpopulations of leukocytes that extravasate into the vein wall as consequence of venous thrombosis; (2) assess the etiologic role of leukocyte sequestration in the vein wall in the inflammatory response to thrombosis by passive immunization of experimental animals with specific monoclonal antibodies to various adhesion molecules (P-selectin, CD18, and ICAM-1); (3) characterize the temporal expression of several cytokines or chemokines in the vein wall in response to venous thrombosis; (4) assess the etiologic role of TNFa in the inflammatory response to thrombosis by passive immunization with a polyclonal antibody to TNFa; and (5) assess the etiologic role of various chemokines in the inflammatory response to thrombosis by passive immunization with appropriate specific, neutralizing antibodies. The proposal will employ a wide variety of immunologic, morphometric, and molecular biologic techniques to achieve these goals.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL053355-01A1
Application #
2231227
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1995-08-01
Project End
1998-07-31
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Surgery
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Henke, P K; Wakefield, T W; Kadell, A M et al. (2001) Interleukin-8 administration enhances venous thrombosis resolution in a rat model. J Surg Res 99:84-91
Henke, P K; DeBrunye, L A; Strieter, R M et al. (2000) Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis. J Immunol 164:2131-41
Wakefield, T W; Linn, M J; Henke, P K et al. (1999) Neovascularization during venous thrombosis organization: a preliminary study. J Vasc Surg 30:885-92
Londy, F J; Kadell, A M; Wrobleski, S K et al. (1999) Detection of perivenous inflammation in a rat model of venous thrombosis using MRV. J Invest Surg 12:151-6
Downing, L J; Strieter, R M; Kadell, A M et al. (1998) Low-dose low-molecular-weight heparin is anti-inflammatory during venous thrombosis. J Vasc Surg 28:848-54
Fowlkes, J B; Strieter, R M; Downing, L J et al. (1998) Ultrasound echogenicity in experimental venous thrombosis. Ultrasound Med Biol 24:1175-82
Downing, L J; Strieter, R M; Kadell, A M et al. (1998) IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. J Immunol 161:1471-6
Downing, L J; Wakefield, T W; Strieter, R M et al. (1997) Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 25:816-27; discussion 828
Wakefield, T W; Strieter, R M; Prince, M R et al. (1997) Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg 5:6-15
Downing, L J; Strieter, R M; Kadell, A M et al. (1996) Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation. ASAIO J 42:M677-82

Showing the most recent 10 out of 11 publications